(0.29%) 5 196.02 points
(0.17%) 38 919 points
(0.20%) 16 381 points
(0.59%) $78.94
(-0.27%) $2.19
(-0.41%) $2 321.60
(-0.20%) $27.56
(2.45%) $988.55
(0.09%) $0.929
(0.71%) $10.90
(0.38%) $0.799
(0.02%) $91.36
-2.23% $ 0.127
Live Chart Being Loaded With Signals
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States...
Stats | |
---|---|
Volumen de hoy | 1.18M |
Volumen promedio | 2.11M |
Capitalización de mercado | 17.88M |
EPS | $0 ( 2024-03-25 ) |
Próxima fecha de ganancias | ( $-0.100 ) 2024-05-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.280 |
ATR14 | $0.00100 (0.79%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-11-01 | Ray Sumita | Buy | 425 000 | Employee Stock option (right to buy) |
2023-11-03 | Paula Molina Rene | Buy | 0 | |
2023-10-02 | Powchik Peter | Buy | 159 744 | Stock option (right to buy) |
2023-10-01 | Ray Sumita | Buy | 0 | |
2023-09-06 | Prime Movers Lab Fund I Lp | Sell | 5 308 | Class A Common Stock |
INSIDER POWER |
---|
55.11 |
Last 91 transactions |
Buy: 6 350 518 | Sell: 2 608 586 |
Volumen Correlación
Vaxxinity, Inc. Correlación
10 Correlaciones Más Positivas | |
---|---|
DUNE | 0.92 |
CIIG | 0.918 |
ONEM | 0.906 |
LGVC | 0.902 |
POAI | 0.902 |
YVR | 0.901 |
MEUSW | 0.894 |
BBCP | 0.886 |
MRNS | 0.876 |
VYGR | 0.876 |
10 Correlaciones Más Negativas | |
---|---|
NYMX | -0.905 |
RANI | -0.903 |
CHCI | -0.903 |
GAIA | -0.898 |
THCP | -0.886 |
GRIN | -0.879 |
ABIO | -0.879 |
CSTE | -0.873 |
CATB | -0.869 |
CADL | -0.844 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Vaxxinity, Inc. Correlación - Moneda/Commodity
Vaxxinity, Inc. Finanzas
Annual | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-2.23M (0.00 %) |
EPS: | $-0.450 |
FY | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-2.23M (0.00 %) |
EPS: | $-0.450 |
FY | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $-1.68M (0.00 %) |
EPS: | $-0.600 |
FY | 2021 |
Ingresos: | $66 000.00 |
Beneficio Bruto: | $-1.87M (-2 834.85 %) |
EPS: | $-1.100 |
Financial Reports:
No articles found.
Vaxxinity, Inc.
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that targets toxic forms of aggregated a-synuclein in the brain to fight Parkinson's disease and other synucleinopathies, such as Lewy body dementia and multiple system atrophy that is in phase 1 clinical trial; and an anti-tau product candidate for various neurodegenerative conditions, including AD. It is also developing UB-313 that targets calcitonin gene-related peptide to fight migraines; anti-PCSK9 that targets proprotein convertase subtilisin/kexin type 9 serine protease to lower low-density lipoprotein cholesterol and reduce the risk of cardiac events; and UB-612 for neutralizing the SARS-CoV-2 virus, which is in phase 3 clinical trial. Vaxxinity, Inc. was founded in 2014 and is headquartered in Dallas, Texas.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico